Wells Fargo & Company Lumos Pharma, Inc. Transaction History

Wells Fargo & Company

  • $410 Billion
  • Q1 2024

A detailed history of Wells Fargo & Company transactions in Lumos Pharma, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 415,551 shares of LUMO stock, worth $731,369. This represents 0.0% of its overall portfolio holdings.

Number of Shares
415,551
Previous 417,051 0.36%
Holding current value
$731,369
Previous $1.33 Million 11.69%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
SELL
$2.64 - $3.22 $3,960 - $4,830
-1,500 Reduced 0.36%
415,551 $1.17 Million
Q4 2023

Feb 09, 2024
BUY
$2.81 - $4.27 $1,410 - $2,143
502 Added 0.12%
417,051 $1.33 Million
Q3 2023

Nov 13, 2023
BUY
$2.63 - $3.49 $248,955 - $330,363
94,660 Added 29.41%
416,549 $1.37 Million
Q2 2023

Aug 15, 2023
BUY
$3.01 - $4.38 $3 - $4
1 Added 0.0%
321,889 $1.06 Million
Q1 2023

May 12, 2023
BUY
$3.16 - $4.0 $11,590 - $14,672
3,668 Added 1.15%
321,888 $1.07 Million
Q4 2022

Feb 13, 2023
SELL
$3.05 - $9.03 $24,689 - $73,097
-8,095 Reduced 2.48%
318,220 $1.15 Million
Q3 2022

Nov 14, 2022
BUY
$7.35 - $9.05 $56,881 - $70,037
7,739 Added 2.43%
326,315 $2.89 Million
Q2 2022

Aug 12, 2022
BUY
$6.68 - $9.39 $2,498 - $3,511
374 Added 0.12%
318,576 $2.45 Million
Q1 2022

May 16, 2022
BUY
$6.58 - $10.09 $14,666 - $22,490
2,229 Added 0.71%
318,202 $2.99 Million
Q4 2021

Feb 14, 2022
SELL
$6.84 - $10.04 $8,290 - $12,168
-1,212 Reduced 0.38%
315,973 $2.19 Million
Q3 2021

Nov 15, 2021
BUY
$7.36 - $11.36 $745,030 - $1.15 Million
101,227 Added 46.87%
317,185 $3.02 Million
Q2 2021

Aug 16, 2021
BUY
$9.75 - $13.44 $486,261 - $670,293
49,873 Added 30.03%
215,958 $2.16 Million
Q1 2021

May 13, 2021
BUY
$11.58 - $31.11 $560,761 - $1.51 Million
48,425 Added 41.16%
166,085 $1.94 Million
Q4 2020

Feb 09, 2021
BUY
$13.61 - $35.91 $17,257 - $45,533
1,268 Added 1.09%
117,660 $4.2 Million
Q3 2020

Nov 05, 2020
BUY
$13.25 - $16.5 $55,517 - $69,135
4,190 Added 3.73%
116,392 $1.61 Million
Q2 2020

Aug 13, 2020
BUY
$7.76 - $16.99 $655,479 - $1.44 Million
84,469 Added 304.58%
112,202 $1.85 Million
Q1 2020

May 14, 2020
BUY
$0.89 - $8.85 $24,682 - $245,437
27,733 New
27,733 $235,000

Others Institutions Holding LUMO

# of Institutions
41
Shares Held
2.29M
Call Options Held
0
Put Options Held
0
View Full List

About LUMOS PHARMA, INC.

LUMO Quotes by TradingView
  • Ticker LUMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,396,070
  • Market Cap $14.8M
  • Description
  • Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...
More about LUMO
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email